返回
A
A. Malmberg
uppsala university
6H指数
28论文数
1.2K被引数
收录论文 4
发表时间
Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAMx4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumorsI/II期剂量递增/扩展试验,旨在评估DuoBody-EpCAMx4-1BB(BNT314/GEN1059)单药或联合免疫检查点抑制剂在恶性实体瘤患者中的安全性与初步疗效。
ANNALS OF ONCOLOGY
IF65.4

